|
Market Closed -
Nasdaq
21:00:00 23/12/2024 GMT
|
5-day change | 1st Jan Change | ||
| 0.2531 USD | +4.20% |
|
-.--% | - |
| 09-18 | Neuphoria Therapeutics Inc. Reports Earnings Results for the Full Year Ended June 30, 2026 | CI |
| 07-23 | Scancell Holdings plc agreed to acquire Neuphoria Therapeutics Inc. for $35 million. | CI |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Data source:
Neuphoria Therapeutics Inc.(NEUP)
EBIT - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
- Stock Market
- Stocks
- NEUP Stock
- BNOX Stock
- Consensus BIONOMICSSADR
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
